Saint-Marcoux Franck, Lachâtre Gérard, Marquet Pierre
Department of Pharmacology and Toxicology, University Hospital, Limoges, France.
J Am Soc Mass Spectrom. 2003 Jan;14(1):14-22. doi: 10.1016/S1044-0305(02)00801-2.
This paper presents an improved, comprehensive liquid chromatography-electrospray-mass spectrometry (LC-ES-MS) general unknown screening (GUS) procedure for drugs and toxic compounds and its comparison with conventional techniques in routine laboratory conditions. Chromatographic separation involved an X-TERRA MS C18, 3.5 microm (100 mm x 1 mm i.d.) column together with a 25-min long gradient of acetonitrile in pH 3, 2 mM ammonium formate delivered at a 50 microl/min flow rate. Two different in-source collision-induced dissociation voltages were alternated, both in the positive and in the negative ion modes. Reconstructed spectra were then obtained in both polarities by adding up spectra obtained with low and high energy, resulting in spectra presenting a sufficient number of specific fragment ions for unambiguous and fast identification of compounds. Two large mass spectral libraries of drugs and toxic compounds were built and an efficient automated signal processing, library searching and report editing algorithm developed. Using a common, efficient solid-phase extraction procedure, this LC-ES-MS technique was compared to GC-MS and HPLC-DAD GUS procedures for the identification of a priori unknown compounds in 51 serum samples consecutively sent to the laboratory for GUS. The present LC-MS method identified 75% of the compounds contained in these samples (versus 66% for GC-MS and 71% for HPLC-DAD), including 8% that the other two techniques failed to identify (versus 8% for GC-MS and 9.5% for HPLC-DAD). Therefore, it is complementary to GC-MS and/or HPLC-DAD and helps enlarge the range of drugs detected in clinical toxicology. It could be useful as well in forensic toxicology to confirm a positive result, as 38% of all the compounds were detected by the three techniques and 36% by two of them.
本文介绍了一种改进的、用于药物和有毒化合物的综合液相色谱 - 电喷雾 - 质谱(LC - ES - MS)通用未知物筛选(GUS)程序,以及在常规实验室条件下其与传统技术的比较。色谱分离采用X - TERRAMS C18,3.5微米(100毫米×1毫米内径)柱,以50微升/分钟的流速输送pH值为3、2 mM甲酸铵中的乙腈,进行25分钟的梯度洗脱。在正离子和负离子模式下,交替使用两种不同的源内碰撞诱导解离电压。然后通过将低能量和高能量获得的光谱相加,在两种极性下获得重建光谱,从而得到具有足够数量特定碎片离子的光谱,用于明确和快速鉴定化合物。构建了两个大型药物和有毒化合物质谱库,并开发了一种高效的自动信号处理、库搜索和报告编辑算法。使用常见的高效固相萃取程序,将这种LC - ES - MS技术与GC - MS和HPLC - DAD GUS程序进行比较,以鉴定连续送到实验室进行GUS的51份血清样品中的先验未知化合物。目前的LC - MS方法鉴定出这些样品中75%的化合物(GC - MS为66%,HPLC - DAD为71%),包括另外两种技术未能鉴定出的8%(GC - MS为8%,HPLC - DAD为9.5%)。因此,它与GC - MS和/或HPLC - DAD互补,有助于扩大临床毒理学中检测到的药物范围。在法医毒理学中,它也可用于确认阳性结果,因为所有化合物中有38%被三种技术检测到,36%被其中两种技术检测到。